1. MARKETS
  2. SECTOR : PHARMA & BIOTECH
  3. INDUSTRY : MAJOR PHARMACEUTICALS
  4. ARBUTUS BIOPHARMA CORP
Arbutus Biopharma Corp XNAS: ABUS
3.93 0.11 (2.88%)
1.0M
XNAS Volume

XNAS 03 Sep, 2025 5:30 PM (EDT)

Arbutus Biopharma Corp - ABUS - stock price prediction, stock price target, analyst ratings from 4 analysts

Arbutus Biopharma Corp has a share price target of US$ 5, revenue growth forecast of 134.6%, and profit growth estimate of 56.5% for FY25, based on top 4 analyst calls.